Evidence map›Paper›PMID 19336558›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2009

Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.

Jeannette M Schenk, Elio Riboli, Nilanjan Chatterjee, Michael F Leitzmann, Jiyoung Ahn, Demetrius Albanes, Douglas J Reding, Yinghui Wang, Marlin D Friesen, Richard B Hayes and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Trial
  4. Serum retinol and risk of prostate cancer.American journal of epidemiology · 2011
    Trial
  5. Review
  6. Associations of Subtype and Isomeric Plasma Carotenoids with Prostate Cancer Risk in Low-Income African and European Americans.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Article
  7. Review
  8. Article
  9. Review
  10. The role of nutritional interventions in prostate cancer: A review.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Vitamins and prostate cancer risk.Molecules (Basel, Switzerland) · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Jeannette M SchenkFred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. jschenk@fhcrc.org
Elio Riboli
Nilanjan Chatterjee
Michael F Leitzmann
Jiyoung Ahn
Demetrius Albanes
Douglas J Reding
Yinghui Wang
Marlin D Friesen
Richard B Hayes
Ulrike Peters
Division of Cancer Epidemiology and GeneticsFred Hutch Cancer Center · USCentre International de Recherche sur le Cancer · FRJohns Hopkins University · USMarshfield Clinic · USUniversity of Regensburg · DE

Funding

Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
PLCO Trial Etiologic and Early Marker StudyZ01CP010152 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI HAYES, RICHARD S · 2000 to 2008
$3.3M
Selenium genetic variation in selenoenzymes and prostate cancerK22CA118421 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2006 to 2008
$468k
NCI NIH HHS K22 CA118421NCI NIH HHS R25 CA094880NCI NIH HHS R25 CA94880
6 · The paper itself

Abstract

Vitamin A (retinol) plays a key role in the regulation of cell growth and differentiation, and has been studied as a potential chemopreventive agent for prostate cancer. However, findings from epidemiologic studies on the association between circulating retinol concentrations and the risk of prostate cancer are inconsistent. We examined whether serum concentrations of retinol were associated with the risk of prostate cancer in a nested case-control study using 692 prostate cancer cases and 844 matched controls from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. We estimated the risk of prostate cancer using multivariate, conditional logistic regression to calculate odds ratios and 95% confidence intervals for overall prostate cancer and aggressive disease (stage III or IV or Gleason >7; n = 269). Serum retinol concentrations were not associated with overall prostate cancer risk; however, the highest versus lowest concentrations of serum retinol were associated with a 42% reduction in aggressive prostate cancer risk (P(trend) = 0.02), with the strongest inverse association for high-grade disease (Gleason sum >7; odds ratio, 0.52; 95% confidence interval, 0.32-0.84; P(trend) = 0.01). Our results suggest that higher circulating concentrations of retinol are associated with a decreased risk of aggressive prostate cancer. Further research is needed to better understand the significance of elevations in serum retinol concentrations and the possible biological mechanisms through which retinol affects prostate cancer.

Indexed as

Mass ScreeningAgedBiomarkers, TumorCase-Control StudiesHumansMaleMiddle AgedNeoplasm StagingOdds RatioProstatic NeoplasmsRisk FactorsSurveys and QuestionnairesUnited StatesVitamin ABiomarkers, TumorVitamin A

Identifiers

PMID19336558
PMCPMC2717001
OpenAlexW2161759026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.